116 related articles for article (PubMed ID: 12605606)
1. Biophysical studies and anti-growth activities of a peptide, a certain analog and a fragment peptide derived from alpha-fetoprotein.
Butterstein G; MacColl R; Mizejewski GJ; Eisele LE; Meservey M
J Pept Res; 2003 Apr; 61(4):213-8. PubMed ID: 12605606
[TBL] [Abstract][Full Text] [Related]
2. Interrelationships among biological activity, disulfide bonds, secondary structure, and metal ion binding for a chemically synthesized 34-amino-acid peptide derived from alpha-fetoprotein.
MacColl R; Eisele LE; Stack RF; Hauer C; Vakharia DD; Benno A; Kelly WC; Mizejewski GJ
Biochim Biophys Acta; 2001 Oct; 1528(2-3):127-34. PubMed ID: 11687299
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics.
Mizejewski GJ; MacColl R
Mol Cancer Ther; 2003 Nov; 2(11):1243-55. PubMed ID: 14617798
[TBL] [Abstract][Full Text] [Related]
4. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
Caceres G; Dauphinee MJ; Eisele LE; MacColl R; Mizejewski GJ
Anticancer Res; 2002; 22(5):2817-20. PubMed ID: 12530002
[TBL] [Abstract][Full Text] [Related]
5. Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs.
Eisele LE; Mesfin FB; Bennett JA; Andersen TT; Jacobson HI; Soldwedel H; MacColl R; Mizejewski GJ
J Pept Res; 2001 Jan; 57(1):29-38. PubMed ID: 11168886
[TBL] [Abstract][Full Text] [Related]
6. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
Mizejewski GJ; Eisele L; Maccoll R
Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
[TBL] [Abstract][Full Text] [Related]
7. Common metal ion coordination in LIM domain proteins.
Kosa JL; Michelsen JW; Louis HA; Olsen JI; Davis DR; Beckerle MC; Winge DR
Biochemistry; 1994 Jan; 33(2):468-77. PubMed ID: 8286377
[TBL] [Abstract][Full Text] [Related]
8. Isolation and structural and functional characterization of two stable peptic fragments of human alpha-fetoprotein.
Dudich I; Tokhtamysheva N; Semenkova L; Dudich E; Hellman J; Korpela T
Biochemistry; 1999 Aug; 38(32):10406-14. PubMed ID: 10441135
[TBL] [Abstract][Full Text] [Related]
9. Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties.
Eisele LE; Mesfin FB; Bennett JA; Andersen TT; Jacobson HI; Vakharia DD; MacColl R; Mizejewski GJ
J Pept Res; 2001 Jun; 57(6):539-46. PubMed ID: 11437957
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
11. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
Mizejewski GJ
Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
[TBL] [Abstract][Full Text] [Related]
12. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects.
Mizejewskia GJ; Butterstein G
Curr Protein Pept Sci; 2006 Feb; 7(1):73-100. PubMed ID: 16472170
[TBL] [Abstract][Full Text] [Related]
13. Development of an active site peptide analog of α-fetoprotein that prevents breast cancer.
Jacobson HI; Andersen TT; Bennett JA
Cancer Prev Res (Phila); 2014 Jun; 7(6):565-73. PubMed ID: 24706695
[TBL] [Abstract][Full Text] [Related]
14. Mixed metal copper(II)-nickel(II) and copper(II)-zinc(II) complexes of multihistidine peptide fragments of human prion protein.
Jószai V; Turi I; Kállay C; Pappalardo G; Di Natale G; Rizzarelli E; Sóvágó I
J Inorg Biochem; 2012 Jul; 112():17-24. PubMed ID: 22542592
[TBL] [Abstract][Full Text] [Related]
15. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
Mizejewski G; Smith G; Butterstein G
Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
[TBL] [Abstract][Full Text] [Related]
16. Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein.
Lipari F; McGibbon GA; Wardrop E; Cordingley MG
Biochemistry; 2001 Feb; 40(5):1196-204. PubMed ID: 11170444
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.
Mekmouche Y; Coppel Y; Hochgräfe K; Guilloreau L; Talmard C; Mazarguil H; Faller P
Chembiochem; 2005 Sep; 6(9):1663-71. PubMed ID: 16078307
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Zn(II) site in the copper-responsive yeast transcription factor, AMT1: a conserved Zn module.
Farrell RA; Thorvaldsen JL; Winge DR
Biochemistry; 1996 Feb; 35(5):1571-80. PubMed ID: 8634288
[TBL] [Abstract][Full Text] [Related]
19. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease.
Liu ST; Howlett G; Barrow CJ
Biochemistry; 1999 Jul; 38(29):9373-8. PubMed ID: 10413512
[TBL] [Abstract][Full Text] [Related]
20. African Viper Poly-His Tag Peptide Fragment Efficiently Binds Metal Ions and Is Folded into an α-Helical Structure.
Watly J; Simonovsky E; Barbosa N; Spodzieja M; Wieczorek R; Rodziewicz-Motowidlo S; Miller Y; Kozlowski H
Inorg Chem; 2015 Aug; 54(16):7692-702. PubMed ID: 26214303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
